Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2003
04/03/2003WO2003027145A1 Cell death inducer, cells and animals expressing the same and method of screening anti-cell death remedy
04/03/2003WO2003027144A1 ENZYME PHOSPHORYLATING Ser46 OF p53
04/03/2003WO2003027143A2 Gene and protein relating to hepatocellular carcinoma
04/03/2003WO2003027142A1 Novel g protein-coupled receptor
04/03/2003WO2003027140A2 Identification of s. typhimurium genes by software-based genome comparison
04/03/2003WO2003027139A2 Novel purified polypeptides involved in membrane biosynthesis
04/03/2003WO2003027138A1 Search for cancer marker by novel screening method
04/03/2003WO2003027137A2 Trimeric conjugates of peptidic derivative
04/03/2003WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
04/03/2003WO2003026705A1 Methods for sterilizing biological materials using flavonoid/flavonol stabilizers
04/03/2003WO2003026689A1 Autologous growth factor cocktail composition, method of production and use
04/03/2003WO2003026566A2 Atlastin
04/03/2003WO2003026494A2 Galectins-1-and-4 in tumor development
04/03/2003WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
04/03/2003WO2003026479A2 Methods of suppressing microglial activation
04/03/2003WO2003026418A2 Methods and compositions for regulation of cell death in plants
04/03/2003WO2003026409A2 Kv1.7 potassium channel disruptions, compositions and methods relating thereto
04/03/2003WO2003026408A1 Model animal with overexpression of regucalcin
04/03/2003WO2003026404A2 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026401A2 Kv3.3b POTASSIUM CHANNEL DISRUPTIONS, COMPOSITIONS AND METHODS RELATED THERETO
04/03/2003WO2003026400A2 METABOTROPIC GLUTAMATE RECEPTOR 4B (mGluR4) DISRUPTIONS, COMPOSITIONS AND METHODS RELATING THERETO
04/03/2003WO2003026399A2 Gng4 gene disruptions, compositions and methods related thereto
04/03/2003WO2003026398A2 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026397A2 Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto
04/03/2003WO2003026396A2 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
04/03/2003WO2003026390A2 Plant reproduction polynucleotides and methods of use
04/03/2003WO2003002722A3 T cell regulatory genes and methods of use thereof
04/03/2003WO2002100317A3 Targeted particles and methods of using the same
04/03/2003WO2002098359A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
04/03/2003WO2002092761A3 Screening assays for agonists or antagonists of cd40 signaling
04/03/2003WO2002092016A3 Therapeutic use of rank antagonists
04/03/2003WO2002088338A3 Method for replicating the hepatitis c virus
04/03/2003WO2002085286A8 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals
04/03/2003WO2002081742A3 Method for the detection of cytochrome b mutations in fungi
04/03/2003WO2002079437A3 Transgenic mice containing abc transporter-like aptase gene disruptions
04/03/2003WO2002077173A3 Polynucleotide encoding a novel immunoglobulin superfamily member, apex4, and variants and splice variants thereof
04/03/2003WO2002077162A3 Gene (t23490) associated with benign prostatic hyperplasia
04/03/2003WO2002077161A3 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses
04/03/2003WO2002077010A3 Method of preventing t-cell mediated responses by map proteins
04/03/2003WO2002073213A3 Assay
04/03/2003WO2002072836A3 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
04/03/2003WO2002070694A3 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell
04/03/2003WO2002070559A3 Nuclear hormone receptor ligand binding domains
04/03/2003WO2002068665A3 Constitutive promoter from arabidopsis
04/03/2003WO2002068465A3 Novel p53-inducible protein
04/03/2003WO2002066513A3 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof
04/03/2003WO2002064097A3 Vegf-d expression in brain cancer
04/03/2003WO2002059306A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/03/2003WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/03/2003WO2002057421A3 Human tumor necrosis factor receptors tr13 and tr14
04/03/2003WO2002057413A3 Peptides for activation and inhibition of delta pkc
04/03/2003WO2002057294A3 Zinc finger proteins for dna binding and gene regulation in plants
04/03/2003WO2002056753A3 P27 prevents cellular migration
04/03/2003WO2002055699A3 Socs (suppressor of cytokine signaling)
04/03/2003WO2002044211A3 Endozepine like protein, polynucleotide encoding them and methods of using the same
04/03/2003WO2002042444A8 Fungal gene cluster associated with pathogenesis
04/03/2003WO2002040670A3 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain
04/03/2003WO2002038760A3 Regulation of human extracellular calcium-sensing g protein-coupled receptor
04/03/2003WO2002032956A3 Human cyclic nucleotide binding protein
04/03/2003WO2002025270A9 Screening systems and methods for identifying modulators of xenobiotic metabolism
04/03/2003WO2002024943A9 Method of identifying osteoregenerative agents using differential gene expression
04/03/2003WO2002024909A9 Receptor nucleic acids and polypeptides
04/03/2003WO2002024742A3 Atp-binding cassette protein
04/03/2003WO2002024723A9 Modified factor viii
04/03/2003WO2002014526A3 Replication competent aav helper functions
04/03/2003WO2002014468A9 Phage-dependent superproduction of biologically active protein and peptides
04/03/2003WO2002014369A9 Human kininogen d5 domain polypeptides and their use
04/03/2003WO2002012524A3 Adenovirus e1b-55k single amino acid mutants and methods of use
04/03/2003WO2002010420A3 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
04/03/2003WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
04/03/2003WO2002009642A9 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
04/03/2003WO2002008404A3 Production of lysosomal enzymes in plants by transient expression
04/03/2003WO2002006445A9 Transgenic mice containing targeted gene disruptions
04/03/2003WO2001072782A9 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/03/2003WO2001072769A9 Methods for purifying highly anionic proteins
04/03/2003US20030066108 Novel plant promoter sequences and methods of use for same
04/03/2003US20030066101 Genetic engineering; modifying the fibre, starch, nitrogen, non-sulfur containing amino acid, anti-nutritional protein, and/or fatty acid content and/or composition in mono-/dicotylendonous plants
04/03/2003US20030066098 Gene expression inhibition; transgenic/animal models
04/03/2003US20030066097 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease
04/03/2003US20030066096 Comprises encapsulated green fluorescent protein, blue fluorescent protein, and/or phycobiliprotein; for use in toys, paints, slimy play material, textiles (clothing), bubbles, ballons, cosmetics, bath powders, lotions, and foods
04/03/2003US20030066095 Wherein linkage between proteins (aequorin and green fluorescent protein (GFP)) stabilizes the system and allow energy transfer via chemiluminescence resonance energy transfer
04/03/2003US20030065162 Controlling genetic expression in monocotyledoneous and dicotyledoneous via wheat protein regulatory sequences
04/03/2003US20030065160 Secreted protein HEMAE80
04/03/2003US20030065159 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065158 Propagation of cattle respiratory syncytial virus; propagate cells, insert synthetic nucleotide sequences codiing phosphoprotein into cell, mutate transfered nucleotide sequences, monitor gene expression
04/03/2003US20030065156 Nucleotide sequence library for use in as diagnostic and therapeutic tools in the treatment of cancer
04/03/2003US20030065151 Secreted protein HCEJQ69
04/03/2003US20030065148 Method for expression of human interferon alpha 1 in Pichia pastoris
04/03/2003US20030065147 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065145 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
04/03/2003US20030065144 Nematode neuromuscular junction GABA receptors and methods related thereto
04/03/2003US20030065143 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030065142 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
04/03/2003US20030065141 Polypeptide for use in the treatment of alzheimer's disease
04/03/2003US20030065140 Novel proteins and nucleic acids encoding same
04/03/2003US20030065139 Nucleotide sequences coding polypeptide for use in the treatment immunological, inflammatory, nervous system and cancer disorders
04/03/2003US20030065138 Linear gamma-carboxyglutamate rich conotoxins
04/03/2003US20030065137 Immunological methods to modulate myostatin in vertebrate subjects
04/03/2003US20030065136 Cyclic peptide for use in the treatment of inflammatory and autoimmune disease
04/03/2003US20030064953 Transferring genes; muscular disorders
1 ... 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 ... 2916